TrialClinical and experimental nephrology2024

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.

Masaomi Nangaku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.